NCNMGF
MXCT icon

Nano-Cap New Millennium Growth Fund’s MaxCyte MXCT Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
1,200,000
+200,000
+20% +$199K 1.14% 28
2026
Q1 		$703K Buy
1,000,000
+770,000
+335% +$719K 0.66% 55
2025
Q4 		$357K Buy
+230,000
New +$367K 0.3% 94

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's MXCT Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its MaxCyte (MXCT) stake by 20% in Q2 2026, buying an estimated $199K and bringing the position to 1,200,000 shares worth $1.48M. The position accounts for 1.14% of the portfolio, ranked #28.

Nano-Cap New Millennium Growth Fund first reported a position in MXCT in Q4 2025 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 1,200,000 shares of MaxCyte worth $1.48M as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 200,000 MaxCyte shares in Q2 2026, an estimated $199K.
  • MaxCyte made up 1.14% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #28 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in MaxCyte in Q4 2025 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.